Providing market intelligence for more than 35 years

In The News

App for COVID-19 contact tracing faces hurdles, generational divide over privacy concerns

A survey of 5,000 adults by Parks Associates indicates roughly half, 52 percent, are willing to share tracking data in an app while 28 percent are unwilling. Twenty percent are willing but only with privacy protection, which falls far short of what experts say is needed.

Still, a high participation rate among young people could be useful in providing symptom assessment tools, which is being done at Brigham Young University.

"You can do daily symptom checking," said Dr. Jennifer Kent, senior director of Parks Associates. "If you think you have symptoms, you can know right there, where do I go to get tested? And does my insurance cover it? And you can get your results back much more quickly."

From the article "App for COVID-19 contact tracing faces hurdles, generational divide over privacy concerns" by David Louie.

Previously In The News

Startup Talk: AT&T Joins Verizon With Announcement Of 5G Network Roadmap, Speeds 100x Faster

Dallas-based marketing research firm Parks Associates has released new mobile research showing 86% of U.S. broadband households now own a smartphone. The smartphone markets in European nations, like i...

Artificial Intelligence + Algorithms = Assumptions!

The public is awakening to this new threat of big data as “Big Brother” while acknowledging all its potential benefits. We do not need many of the idiocies promoted for profit in the Internet of Thing...

Prediction: Wi-Fi-Cell Hybrid Service Is Coming

As always, timing is everything. Research published in July by Parks Associates suggests U.S. mobile carriers are shifting their focus from ARPU growth to churn management as new smartphone users beco...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...